Vimarsana
Biggest News Aggregation in the World

6brooklyn Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 6brooklyn Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 6brooklyn Research Today - Breaking & Trending Today

Demand for Weight-Loss Drugs Spikes Despite Horror Stories - Vimarsana News

Demand for Weight-Loss Drugs Spikes Despite Horror Stories

Side effects including nausea, diarrhea, constipation, stomach pain and other stomach issues can't stop prices skyrocketing.

Affordable prescription drugs need bipartisan patent reform - Vimarsana News

Affordable prescription drugs need bipartisan patent reform

Like food, gas, and other essential products, the public is now paying more for prescription drugs than ever before. In January alone, drug manufacturers raised the price of more than 910 major brand-name drugs by 5% on average, according to the drug price nonprofit 46Brooklyn Research. Between 2011 and 2021, America’s annual spending on prescription

2024's drug price hikes are rolling in — and some decreases : Shots - Vimarsana News

2024's drug price hikes are rolling in — and some decreases : Shots

Spoiler: There are some decreases this year, too. Here's an overview of the changing prices and what to make of them.

Source: npr.org
What to know about January's annual drug price hikes - Vimarsana News

What to know about January's annual drug price hikes

Spoiler: There are some decreases this year, too. Here's an overview of the changing prices and what to make of them.

Source: wsiu.org
What We're Reading: Health Insurance Premiums; Drug Price Hikes; Postpartum Depression Pill Access - Vimarsana News

What We're Reading: Health Insurance Premiums; Drug Price Hikes; Postpartum Depression Pill Access

Families with workplace health insurance may have missed out on $125,000 in earnings over the past 3 decades due to rising premiums; so far, there have been about 600 drug price hikes in January; experts worry that minority and low-income people will not have easy access to zuranolone, the first FDA-approved postpartum depression pill.

Source: ajmc.com